Skip to main content
SpringerLink
Log in

Multiple sclerosis: a unique immunopathological syndrome of the central nervous system

  • Published:
Springer Seminars in Immunopathology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. AUSTIMS Research Group (1989) Interferon-α and transfer factor in the treatment of multiple sclerosis: a double-blind, placebo-controlled trial. J Neurol Neurosurg Psychiatry 52:566.

    Google Scholar 

  2. Avrameas S, Ternynck T (1993) The natural autoantibodies system: between hypotheses and facts. Mol Immunol 30:1133.

    Google Scholar 

  3. Back SA, Alhadeff JA (1992) Differential isoform profiles of α2-macroglobulin from plasma of patients with chronic-progressive or relapsing-remitting multiple sclerosis. Clin Chim Acta 211:27.

    Google Scholar 

  4. Baig S, Olsson O, Olsson T, Love A, Jeansson S, Link H (1989) Cells producing antibody to measles and herpes simplex virus in cerebrospinal fluid and blood of patients with multiple sclerosis and controls. Clin Exp Immunol 78:390.

    Google Scholar 

  5. Barnes D, Munro PM, Youl BD, Prineas JW, McDonald WI (1991) The longstanding MS lesion. A quantitative MRI and electron microscopic study. Brain 114:1271.

    Google Scholar 

  6. Beck J, Rondot P, Jullien P, Wietzerbin J, Lawrence DA (1991) TGF-β-like activity produced during regression of exacerbations in multiple sclerosis. Acta Neurol Scand 84:452.

    Google Scholar 

  7. Beck RW, Cleary PA, Trobe JD, Kaufman DI, Kupersmith MJ, Paty DW, Brown CH, Group ONT (1993) The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. N Engl J Med 329:1764.

    Google Scholar 

  8. Benvenuto R, Paroli M, Buttinelli C, Franco A, Barnaba V, Fieschi C, Balsano F (1991) Tumour necrosis factor-α synthesis by cerebrospinal fluid-derived T cell clones from patients with multiple sclerosis. Clin Exp Immunol 84:97.

    Google Scholar 

  9. Booss J, Esiri MM, Tourtellotte WW, Mason DY (1983) Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J Neurol Sci 62:219.

    Google Scholar 

  10. Brueck W, Schmied M, Suchanek G, Brueck Y, Breitschopf H, Poser S, Piddleston S, Lassman H (1994) Oligodendrocytes in the early course of multiple sclerosis. Ann Neurol 35:65.

    Google Scholar 

  11. Cacabelos R, Barquero M, Garcia P, Alvarez XA, Varela de SE (1991) Cerebrospinal fluid interleukin-1β (IL-1β) in Alzheimer's disease and neurological disorders. Methods Find Exp Clin Pharmacol 13:455.

    Google Scholar 

  12. Chen IS, Haislip AM, Myers LW, Ellison GW, Merrill JE (1990) Failure to detect human T cell leukemia virus-related sequences in multiple sclerosis blood. Arch Neurol 47:1064.

    Google Scholar 

  13. Chofflon M, Weiner HL, Morimoto C, Hafler DA (1988) Loss of functional suppression is linked to decreases in circulating suppressor inducer (CD4+ 2H4+) T cells in multiple sclerosis. Ann Neurol 24:185.

    Google Scholar 

  14. Chofflon M, Weiner HL, Morimoto C, Hafler DA (1989) Decrease of suppressor inducer (CD4+ 2H4+) T cells in multiple sclerosis cerebrospinal fluid. Ann Neurol 25:494.

    Google Scholar 

  15. Coyle PK (1985) CSF immune complexes in multiple sclerosis. Neurology 35:429.

    Google Scholar 

  16. Dighiero G, Lymberi P, Guilbert B, Temynck T, Avrameas S (1986) Natural autoantibodies constitute a substantial part of normal circulating immunoglobulins. Ann NY Acad Sci 475:135.

    Google Scholar 

  17. Farrell MA, Kaufmann JC, Gilbert JJ, Noseworthy JH, Armstrong HA, Ebers GC (1985) Oligoclonal bands in multiple sclerosis: clinical-pathological correlation. Neurology 35:212.

    Google Scholar 

  18. Fredrikson S, Karlsson-Parra A, Olsson T, Link H (1987) HLA-DR antigen expression on T cells from cerebrospinal fluid in multiple sclerosis and aseptic meningo-encephalitis. Clin Exp Immunol 68:298.

    Google Scholar 

  19. Freedman MS, Muth KL, Trotter JL, Yoshizawa CN, Antel JP (1992) Prospective serial analysis of interleukin-2 and soluble interleukin-2 receptor in relapsing-remitting multiple sclerosis. Neurology 42:1596.

    Google Scholar 

  20. Frei K, Fredrikson S, Fontana A, Link H (1991) Interleukin-6 is elevated in plasma in multiple sclerosis. J Neuroimmunol 31:147.

    Google Scholar 

  21. Gallo P, Piccinno MG, Tavolato B, Siden A (1991) A longitudinal study on IL-2, sIL-2R, IL-4 and IFN-gamma in multiple sclerosis CSF and serum. J Neurol Sci 101:227.

    Google Scholar 

  22. Ghatak NR, Leshner RT, Price AC, Felton III WL (1989) Remyelination in the human central nervous system. J Neuropathol Exp Neurol 48:507.

    CAS  PubMed  Google Scholar 

  23. Giang DW, Grow VM, Mooney C, Mushlin AI, Goodman AD, Mattson DH, Schiffer RB (1994) Clinical diagnosis of multiple sclerosis. The impact of magnetic resonance imaging and ancillary testing. Rochester-Toronto Magnetic Resonance Study Group. Arch Neurol 51:61.

    Google Scholar 

  24. Gorny MK, Wroblewska Z, Pleasure D, Miller SL, Wajgt A, Koprowski H (1983) CSF antibodies to myelin basic protein and oligodendrocytes in multiple sclerosis and other neurological diseases. Acta Neurol Scand 67:338.

    Google Scholar 

  25. Hafler DA, Hemler ME, Christenson L, Williams JM, Shapiro HM, Strom TB, Strominger JL, Weiner HL (1985) Investigation of in vivo activated T cells in multiple sclerosis and inflammatory central nervous system diseases. Clin Immunol Immunopathol 37:163.

    Google Scholar 

  26. Halawa I, Lolli F, Link H (1989) Terminal component of complement C9 in CSF and plasma of patients with MS and aseptic meningitis. Acta Neurol Scand 80:130.

    Google Scholar 

  27. Hammann KP, Hopf HC (1986) Determination of interferon-gamma in the peripheral blood of multiple sclerosis patients in remission, using a chemiluminescence technique. J Neuroimmunol 13:9.

    Google Scholar 

  28. Hartung HP, Reiners K, Schmidt B, Stoll G, Toyka KV (1991) Serum interleukin-2 concentrations in Guillain-Barre syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis. Ann Neurol 30:48.

    Google Scholar 

  29. Hauser SL, Bhan AK, Gilles F, Kemp M, Kerr C, Weiner HL (1986) Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Ann Neurol 19:578.

    Google Scholar 

  30. Hayano M, Sung JH, Mastri AR (1976) “Paramyxovirus-like” intranuclear inclusions occurring in the nervous system in diverse unrelated conditions. J Neuropathol Exp Neurol 35:287.

    Google Scholar 

  31. Hedlund G, Sandberg-Wollheim M, Sjogren HO (1989) Increased proportion of CD4+CDw29+ CD45R−UCHL-1+ lymphocytes in the cerebrospinal fluid of both multiple sclerosis patients and healthy individuals. Cell Immunol 118:406.

    Google Scholar 

  32. Henriksson A, Kam-Hansen S, Forsberg P, Grandien M (1986) Cerebrospinal fluid lymphocytes from patients with multiple sclerosis do not increase immunoglobulin or measles antibody production after stimulation with pokeweed mitogen. J Neuroimmunol 11:15.

    Google Scholar 

  33. Hertzog PJ, Wright A, Harris G, Linnane AW, Mackay IR (1991) Intermittent interferonemia and interferon responses in multiple sclerosis. Clin Immunol Immunopathol 58:18.

    Google Scholar 

  34. Huberman M, Shalit F, Roth-Deri I, Gutman B, Kott E, Sredni B (1993) Decreased IL-3 production by peripheral blood mononuclear cells in patients with multiple sclerosis. J Neurol Sci 118:79.

    Google Scholar 

  35. Ichioka T, Uobe K, Stoskopf M, Kishimoto Y, Tennekoon G, Tourtellotte WW (1988) Antigalactocerebroside antibodies in human cerebrospinal fluids determined by enzyme-linked immunosorbent assay (ELISA). Neurochem Res 13:203.

    Google Scholar 

  36. Jingwu Z, Medaer R, Hashim GA, Chin Y, van den Berg LE, Raus JC (1992) Myelin basic proteinspecific T lymphocytes in multiple sclerosis and controls: precursor frequency, fine specificity, and cytotoxicity. Ann Neurol 32:330.

    Google Scholar 

  37. Kerlero de RN, Milo R, Lees MB, Burger D, Bernard CC, Ben-Nun A (1993) Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. J Clin Invest 92:2602.

    Google Scholar 

  38. Kolmel HW, Sudau C (1989) Cell count and ratio of helper/inducer to suppressor/cytotoxic T cells in the cerebrospinal fluid of patients with multiple sclerosis. J Neurol 236:424.

    Google Scholar 

  39. Lee SC, Raine CS (1989) Multiple sclerosis: oligodendrocytes in active lesions do not express class II major histocompatibility complex molecules. J Neuroimmunol 25:261.

    Google Scholar 

  40. Lee SC, Moore GR, Golenwsky G, Raine CS (1990) Multiple sclerosis: a role for astroglia in active demyelination suggested by class II MHC expression and ultrastructural study. J Neuropathol Exp Neurol 49:122.

    Google Scholar 

  41. Lolli F, Halawa I, Link H (1989) Intrathecal synthesis of IgG, IgA, IgM and IgD in untreated multiple sclerosis and controls. Acta Neurol Scand 80:238.

    Google Scholar 

  42. Losy J, Mehta PD, Wisniewski HM (1990) Identification of IgG subclasses' oligoclonal bands in multiple sclerosis CSF. Acta Neurol Scand 82:4.

    Google Scholar 

  43. Lubetzki C, Lombrail P, Hauw JJ, Zalc B (1986) Multiple sclerosis: rat and human oligodendrocytes are not the target for CSF immunoglobulins. Neurology 36:524.

    Google Scholar 

  44. Maimone D, Gregory S, Arnason BG, Reder AT (1991) Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis. J Neuroimmunol 32:67.

    Google Scholar 

  45. Martin JR, Holt RK, Webster HD (1988) Herpes-simplex-related antigen in human demyelinative disease and encephalitis. Acta Neuropathol 76:325.

    Google Scholar 

  46. Martino G, Olsson T, Fredrikson S, Hojeberg B, Kostulas V, Grimaldi LM, Link H (1991) Cells producing antibodies specific for myelin basic protein region 70–89 are predominant in cerebrospinal fluid from patients with multiple sclerosis. Eur J Immunol 21:2971.

    Google Scholar 

  47. Matsiota P, Blancher A, Doyon B, Guilbert B, Clanet M, Kouvelas ED, Avrameas S (1988) Comparative study of natural autoantibodies in the serum and cerebrospinal fluid of normal individuals and patients with multiple sclerosis and other neurological diseases. Ann Inst Pasteur Immunol 139:99.

    Google Scholar 

  48. Matsuda M, Tsukada N, Miyagi K, Yanagisawa N (1991) Increased interleukin-1 production by peripheral blood mononuclear cells in patients with multiple sclerosis. J Neurol Sci 102:100.

    Google Scholar 

  49. McCallum K, Esiri MM, Tourtellotte WW, Booss J (1987) T cell subsets in multiple sclerosis. Gradients at plaque borders and differences in nonplaque regions. Brain 110:1297.

    Google Scholar 

  50. Meinl E, Weber F, Drexler K, Morelle C, Ott M, Saruhan-Direskeneli G, Goebels N, Ertl B, Jechart G, Giegerich G, Schonbeck S, Bannwarth W, Wekerle H, Hohlfeld R (1993) Myelin basic proteinspecific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones. J Clin Invest 92:2633.

    Google Scholar 

  51. Miller DJ, Sanborn KS, Katzmann JA, Rodriguez M (1994) Monoclonal autoantibodies promote central nervous system repair in an animal model of multiple sclerosis. J Neurosci 14:6230.

    Google Scholar 

  52. Mix E, Olsson T, Correale J, Kostulas V, Link H (1990) CD4+, CD8+, and CD4− CD8− T cells in CSF and blood of patients with multiple sclerosis and tension headache. Scand J Immunol 31:493.

    Google Scholar 

  53. Moller JR, Johnson D, Brady RO, Tourtellotte WW, Quarles RH (1989) Antibodies to myelin-associated glycoprotein (MAG) in the cerebrospinal fluid of multiple sclerosis patients. J Neuroimmunol 22:55.

    Google Scholar 

  54. Muller FA, Hanny PE, Wichmann W, Fierz W, Dursteier MR (1989) Cerebrospinal fluid immunoglobulins and multiple sclerosis. Correspondence with magnetic resonance imaging and visually evoked potential changes. Arch Neurol 46:367.

    Google Scholar 

  55. Nesbit GM, Forbes GS, Scheithauer BW, Okazaki H, Rodriguez M (1991) Multiple sclerosis: histopathological and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. Radiology 180:467.

    Google Scholar 

  56. Nobile-Orazio E, Spagnol G, Daverio R, Riboni L, Macchi R, Francomano E, Scarlato G (1987) Studies on anti-myelin antibodies in patients with multiple sclerosis. Riv Neurol 57:13.

    Google Scholar 

  57. Panitch HS, Hirsch RL, Haley AS, Johnson KP (1987) Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet I:893.

    Google Scholar 

  58. Paty DW, Li DK (1993) Interferon-β-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group. Neurology 43:662.

    Google Scholar 

  59. Pedersen JS, Walker M, Toh BH, De Aizpurua HJ, Lolait SJ, Bernard CCA (1983) Flow microfluorometry detects IgM autoantibody to oligodendrocytes in multiple sclerosis. J Neuroimmunol 5:251.

    Google Scholar 

  60. Perrella O, Carrieri PB, De MR, Buscaino GA (1993) Markers of activated T lymphocytes and T cell receptor γ/δ+ in patients with multiple sclerosis. Eur Neurol 33:152.

    Google Scholar 

  61. Polman CH, de GCJ, Koetsier JC, Sminia T, Veerman AJ (1987) Cerebrospinal fluid cells in multiple sclerosis and other neurological diseases: an immunocytochemical study. J Neurol 234:19.

    Google Scholar 

  62. Prayoonwiwat N, Pease LR, Rodriguez M (1991) Human T cell lymphotropic virus type I sequences detected by nested polymerase chain reactions are not associated with multiple sclerosis. Mayo Clin Proc 66:665.

    Google Scholar 

  63. Prineas JW, Connell F (1978) The fine structure of chronically active multiple sclerosis plaques. Neurology 28:68.

    Google Scholar 

  64. Prineas JW, Connell F (1979) Remyelination in multiple sclerosis. Ann Neurol 5:22.

    Google Scholar 

  65. Prineas JW, Wright RG (1978) Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab Invest 38:409.

    Google Scholar 

  66. Prineas JW, Kwon EE, Goldenberg PZ, Ilyas AA, Quarles RH, Benjamins JA, Sprinkle TJ (1989) Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions. Lab Invest 61:489.

    CAS  PubMed  Google Scholar 

  67. Prineas JW, Barnard RO, Kwon EE, Sharer LR, Cho ES (1993) Multiple sclerosis: remyelination of nascent lesions. Ann Neurol 33:137.

    Google Scholar 

  68. Prineas JW, Barnard RO, Revesz T, Kwon EE, Sharer L, Cho ES (1993) Multiple sclerosis. Pathology of recurrent lesions. Brain 116:681.

    Google Scholar 

  69. Procaccia S, Lanzanova D, Caputo D, et al. (1988) Circulating immune complexes in serum and in cerebrospinal fluid of patients with multiple sclerosis. Characterization and correlation with the clinical course. Acta Neurol Scand 77:373.

    Google Scholar 

  70. Raine CS, Traugott U, Stone SH (1978) Chronic relapsing experimental allergic encephalomyelitis: CNS plaque development in unsuppressed and suppressed animals. Acta Neuropathol (Berl) 43:43.

    Google Scholar 

  71. Rodriguez M, Lennon VA (1990) Immunoglobulins promote remyelination in the central nervous system. Ann Neurol 27:12.

    Google Scholar 

  72. Rodriguez M, Sheithauer B (1994) Ultrastructure of multiple sclerosis. Ultrastruct Pathol 18:3.

    Google Scholar 

  73. Rodriguez M, Wynn DR, Kimlinger TK, Katzmann JA (1990) Terminal component of complement (C9) in the cerebrospinal fluid of patients with multiple sclerosis and neurological controls. Neurology 40:855.

    Google Scholar 

  74. Rodriguez M, Karnes WE, Bartleson JD, Pineda AA (1993) Plasmapheresis in acute episodes of fulminant CNS inflammatory demyelination. Neurology 43:1100.

    Google Scholar 

  75. Rodriguez M, Scheithauer BW, Forbes G, Kelly PJ (1993) Oligodendrocyte injury is an early event in lesions of multiple sclerosis. Mayo Clin Proc 68:627.

    Google Scholar 

  76. Rodriguez M, Siva A, Ward J, Stolp-Smith K, O'Brien P, Kurland L (1994) Impairment, disability, and handicap in multiple sclerosis: a population-based study in Olmsted County, Minnesota. Neurology 44:28.

    Google Scholar 

  77. Ruijs TC, Freedman MS, Grenier YG, Olivier A, Antel JP (1990) Human oligodendrocytes are susceptible to cytolysis by major histocompatibility complex class I-restricted lymphocytes. J Neuroimmunol 27:89.

    Google Scholar 

  78. Salmi AA, Hyypia T, Ilonen J, Reunanen M, Remes M (1989) Production of viral antibodies in vitro by CSF cells from mumps meningitis and multiple sclerosis patients. J Neurol Sci 90:315.

    Google Scholar 

  79. Sanders ME, Koski CL, Robbins D, Shin ML, Frank MM, Joiner KA (1986) Activated terminal complement in cerebrospinal fluid in Guillain-Barre syndrome and multiple sclerosis. J Immunol 136:4456.

    Google Scholar 

  80. Scolding NJ, Morgan BP, Houston WA, Linington C, Campbell AK, Compston DA (1989) Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement. Nature 339:620.

    Google Scholar 

  81. Selmaj K, Nowak Z, Tchorzewski H (1988) Multiple sclerosis: effect of myelin basic protein on interleukin 1, interleukin 2 production and interleukin 2 receptor expression in vitro. Clin Exp Immunol 72:428.

    Google Scholar 

  82. Selmaj K, Brosnan CF, Raine CS (1991) Colocalization of lymphocytes bearing γδ T cell receptor and heat shock protein hsp65+ oligodendrocytes in multiple sclerosis. Proc Natl Acad Sci USA 88:6452.

    Google Scholar 

  83. Selmaj K, Raine CS, Cannella B, Brosnan CF (1991) Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 87:949.

    Google Scholar 

  84. Sharief MK, Hentges R (1991) Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis. N Engl J Med 325:467.

    Google Scholar 

  85. Sobel RA, Hafler DA, Castro EE, Morimoto C, Weiner HL (1988) The 2H4 (CD45R) antigen is selectively decreased in multiple sclerosis lesions. J Immunol 140:2210.

    Google Scholar 

  86. Sobel RA, Mitchell ME, Fondren G (1990) Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system. Am J Pathol 136:1309.

    Google Scholar 

  87. Soderstrom M, Link H, Sun JB, Fredrikson S, Kostulas V, Hojeberg B, Li BL, Olsson T (1993) T cells recognizing multipe peptides of myelin basic protein are found in blood and enriched in cerebrospinal fluid in optic neuritis and multiple sclerosis. Scand J Immunol 37:355.

    Google Scholar 

  88. Sun J, Link H, Olsson T, Xiao BG, Andersson G, Ekre HP, Linington C, Diener P (1991) T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. J Immunol 146:1490.

    Google Scholar 

  89. Sun JB, Olsson T, Wang WZ, Xiao BG, Kostulas V, Fredrikson S, Ekre HP, Link H (1991) Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls. Eur J Immunol 21:1461.

    Google Scholar 

  90. Tanaka R, Iwazaki Y, Koprowski H (1975) Ultrastructural studies of perivascular cuffing cells in multiple sclerosis brain. Am J Pathol 81:467.

    Google Scholar 

  91. Tourtellotte WW, Baumhefner RW, Syndulko K, etal (1988) The long march of the cerebrospinal fluid profile indicative of clinical definite multiple sclerosis; and still marching. J Neuroimmunol 20:217.

    Google Scholar 

  92. Traugott U (1987) Multiple sclerosis: relevance of class I and class II MHC-expressing cells to lesion development. J Neuroimmunol 16:283.

    Google Scholar 

  93. Traugott U, Lebon P (1988) Interferon-γ and Ia antigen are present on astrocytes in active chronic multiple sclerosis lesions. J Neurol Sci 84:257.

    Google Scholar 

  94. Trotter JL, Collins KG, van der Veen RC (1991) Serum cytokine levels in chronic progressive multiple sclerosis: interleukin-2 levels parallel tumor necrosis factor-α levels. J Neuroimmunol 33:29.

    Google Scholar 

  95. Tsukada N, Behan WM, Behan PO (1985) Search for autoantibodies to endothelial and smooth muscle cells in patients with multiple sclerosis. Acta Neuropathol (Berl) 66:134.

    Google Scholar 

  96. Van Engelen BGM, Hommes OR, Pinckers A, Cruysberg JRM, Barkhof F, Rodriguez M (1992) Improved vision after intravenous immunoglobulin in stable demyelinating optic neuritis. Ann Neurol 32:834.

    Google Scholar 

  97. Vrethem M, Ernerudh J, Lindstrom F, Skogh T (1990) Immunoglobulins within the central nervous system in primary Sjogren's syndrome. J Neurol Sci 100:186.

    Google Scholar 

  98. Warren KG, Catz I (1989) Cerebrospinal fluid autoantibodies to myelin basic protein in multiple sclerosis patients. Detection during first exacerbations and kinetics of acute relapses and subsequent convalescent phases. J Neurol Sci 91:143.

    Google Scholar 

  99. Weber WE, Buurman WA, Vandermeeren MM, Medaer RH, Raus JC (1987) Fine analysis of cytolytic and natural killer T lymphocytes in the CSF in multiple sclerosis and other neurological diseases. Neurology 37:419.

    Google Scholar 

  100. Weiner HL, Dau PC, Khatri BO, Petajan JH, Birnbaum G, McQuillen MP, Fosburg MT, Feldstein M, Orav EJ (1989) Double-blind study of true vs sham plasma exchange in patients treated with immunosuppression for acute attacks of multiple sclerosis. Neurology 39:1143.

    Google Scholar 

  101. Woyciechowska JL, Dambrozia J, Leinikki P, Shekarchi C, Wallen W, Sever J, McFarland H, McFarlin D (1985) Viral antibodies in twins with multiple sclerosis. Neurology 35:1176.

    Google Scholar 

  102. Wucherpfennig KW, Newcombe J, Li H, Keddy C, Cuzner ML, Hafler DA (1992) γδ T-cell receptor repertoire in acute multiple sclerosis lesions. Proc Natl Acad Sci USA 89:4588.

    Google Scholar 

  103. Wucherpfennig KW, Newcombe J, Li H, Keddy C, Cuzner ML, Hafler DA (1992) T cell receptor Vα-Vβ repertoire and cytokine gene expression in active multiple sclerosis lesions. J Exp Med 175:993.

    Google Scholar 

  104. Wynn DR, Rodriguez M, O'Fallon WM, Kurland LT (1990) A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota. Neurology 40:780.

    Google Scholar 

  105. Zeman A, McLean B, Keir G, Luxton R, Sharief M, Thompson E (1993) The significance of serum oligoclonal bands in neurological diseases. J Neurol Neurosurg Psychiatry 56:32.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Mayo Clinic and Mayo Foundation, 55905, Rochester, MN, USA

    Samuel F. Hunter & Moses Rodriguez

  2. Department of Immunology, Mayo Clinic and Mayo Foundation, 55905, Rochester, MN, USA

    Moses Rodriguez

Authors
  1. Samuel F. Hunter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Moses Rodriguez
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hunter, S.F., Rodriguez, M. Multiple sclerosis: a unique immunopathological syndrome of the central nervous system. Springer Semin Immunopathol 17, 89–105 (1995). https://doi.org/10.1007/BF00194102

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00194102

Keywords

Search

Navigation